XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net income (loss) $ (12,550) $ 848
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, depletion, accretion, and amortization 8,181 6,985
Impairment of oil and natural gas properties 6,495 0
Deferred income taxes (452) (2,460)
Total commodity derivative (gains) losses, net (704) 4,944
Commodity derivative settlements paid (642) (6,099)
Loss on marketable equity securities (54) 85
Impairment and loss on real estate held for sale 0 75
Amortization of debt issuance costs 37 32
Stock-based compensation 1,951 2,594
Right of use asset amortization 135 140
Changes in operating assets and liabilities:    
Oil and natural gas sales receivable (292) (3,587)
Other assets 395 320
Accounts payable and accrued liabilities 1,047 5,456
Accrued compensation and benefits (294) (479)
Payments on operating lease liability (145) (68)
Payments on asset retirement obligations (131) (289)
Net cash provided by operating activities 2,977 8,497
Cash flows from investing activities:    
Acquisition of proved properties 0 (12,610)
Oil and natural gas capital expenditures (2,878) (5,369)
Property and equipment expenditures (487) (379)
Proceeds from sale of oil and gas properties 0 1,250
Net cash used in investing activities (3,365) (17,108)
Cash flows from financing activities:    
Borrowings on credit facility 500 15,200
Repayment of debt (500) (6,047)
Payment of fees for credit facility 0 (207)
Repayments of insurance premium finance note payable (465) (396)
Exercise of warrant 0 195
Shares withheld to settle tax withholding obligations for restricted stock awards 151 307
Dividends paid (1,192) (1,156)
Repurchases of common stock (241) 0
Net cash used in financing activities (2,049) 7,282
Net decrease in cash and equivalents (2,437) (1,329)
Cash and equivalents, beginning of period 4,411 4,422
Cash and equivalents, end of period $ 1,974 $ 3,093